Wigmore_Amy

Amy Kreiger Wigmore

Wigmore_Amy

Amy Kreiger Wigmore

Partner

  • Vice Chair, Litigation/Controversy Department

Amy Wigmore is a first-chair trial lawyer with more than 20 years of experience managing complex litigation, focusing primarily on technology disputes. She is vice chair of the firm's Litigation/Controversy Department and a member of the Intellectual Property Litigation Practice.

Ms. Wigmore is widely known for her trial work. She is a fellow of the Litigation Counsel of America, and she has been recognized as a leading IP Litigation practitioner by several publications, including Chambers, LMG Life Sciences, and Managing IP.

Ms. Wigmore has extensive experience representing clients in the pharmaceutical, biotechnology and medical device industries. She has participated in several jury trials and secured multiple verdicts exceeding $500,000 on behalf of her clients. Ms. Wigmore also has played a leading role in bench trials, arbitrations and appellate matters.

In addition to her patent litigation experience, Ms. Wigmore has represented clients in cases involving the misappropriation of trade secrets, unfair competition, breach of contract, employment disputes, civil rights claims and test security issues.

 
  • Amy Wigmore Recognized Among Nation's Best for Intellectual Property Litigation

    Chambers USA announced its rankings for the 2018 edition and named Partner Amy Wigmore as a leader in her field.

    May 3, 2018
    Read More
  • Amy Wigmore Named Among the Top 250 Women in IP

    Managing Intellectual Property's 2018 IP Stars Handbook recognizes Partner Amy Wigmore for her knowledge, outcomes achieved for clients and unique strengths in her given practice area.

    May 17, 2018
    Read More

Experience

    • Participated a jury trial resulting in a $539 million damages award for a technology client.
    • Currently serving as lead counsel for a pharmaceutical company in a Hatch-Waxman case involving multiple generic challenges to patents covering a blockbuster drug product.
    • Secured a victory for a pharmaceutical company in a jury trial on patent validity and obtained a $2.15 billion settlement for patent infringement damages resulting from an “at-risk” launch of a generic pharmaceutical product. 
    • Represented a biotechnology company in a highly successful five-year legal battle involving a licensing dispute with a major clinical diagnostics company. The 10-week jury trial resulted in a $505 million verdict for our client and ultimately led to a $1.4 billion acquisition of our client by the defendant. 
    • Represented a major pharmaceutical company in multiple jury trials, bench trials, and US and international arbitrations involving biotechnology patents. 
    • Achieved a favorable jury verdict for a medical device company in patent litigation concerning safety needles and blood collection devices.
    • Successfully argued on behalf of a pharmaceutical company for dismissal of patent infringement allegations concerning a biotechnology patent on the grounds that the asserted claims were unpatentable. 
    • Served as lead counsel for a power wheelchair manufacturer in defending against patent infringement allegations. 
    • Represented a medical device company in defending a patent infringement case involving surgical ablation devices. 
    • Successfully argued in the Federal Circuit for dismissal of the appeal of an inter partes reexam in which the patent claims asserted against a medical device manufacturer were found invalid. 
    • Represented a pharmaceutical company in the appeals of Hatch-Waxman cases involving treatments for Hepatitis C and HIV. 
    • Successfully represented a pharmaceutical company in a Hatch-Waxman patent infringement case involving a treatment for HIV. 
    • Served as lead counsel for in a patent infringement case involving biotechnology. 
    • Served as lead counsel for the defendant in a patent infringement case concerning digital audio technology. 
    • Represented a pharmaceutical company in a license dispute concerning drug-eluting stents.
    • Successfully represented a pharmaceutical company in a Hatch-Waxman patent infringement case involving a treatment for Parkinson's disease.
       

Recognition

  • Award Text

    Top 250 Women in IP

    Managing IP

    2018

  • Award Text

    Life Sciences Star for Intellectual Property

    LMG Life Sciences

    2016-2018

  • Award Text

    Leading Lawyer for Intellectual Property Litigation

    Chambers USA

    2017-2019

  • Fellow, Litigation Counsel of America
  • Recognized in the 2017–2019 editions of Chambers USA: America's Leading Lawyers for Business for her Washington DC intellectual property litigation practice
  • Recommended in the 2016 and 2017 editions of The Legal 500 United States for healthcare: life sciences and intellectual property: patents: prosecution
  • Shortlisted in the “General Patent Litigator of the Year – District of Columbia” category in 2018, named a Life Sciences Star in 2016–2018 for intellectual property and named to the 2017 awards shortlist for Hatch-Waxman Litigator of the Year: Branded by LMG Life Sciences
  • Recognized in 2013–2019 as a leader in her field and an IP Star by Managing IP and consistently featured in its accompanying Top 250 Women in IP list
 

Insights & News

Credentials

  • Education

    • JD, Harvard Law School, 1995

      magna cum laude
    • BA, University of Massachusetts, 1992

      Phi Beta Kappa
  • Admissions

    • District of Columbia

    • Massachusetts

    • US Supreme Court

    • US Court of Appeals for the District of Columbia Circuit

    • US Court of Appeals for the Federal Circuit

    • US Court of Appeals for the Sixth Circuit

    • US District Court for the District of Colorado

    • US District Court for the District of Columbia

    • US District Court for the District of Massachusetts

Credentials